BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Virginia Bleeding Disorders Foundation - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://vahemophilia.org
X-WR-CALDESC:Events for Virginia Bleeding Disorders Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260303T190000
DTEND;TZID=America/New_York:20260303T201500
DTSTAMP:20260502T012755
CREATED:20260204T005044Z
LAST-MODIFIED:20260210T003331Z
UID:7223-1772564400-1772568900@vahemophilia.org
SUMMARY:VIRTUAL - Education Session "Discover a New  Investigational Approach  to VWD Treatment"
DESCRIPTION:RSVP HERE!\nJoin Us for a Virtual Education Session during VWD Awareness Week\nMarch is Bleeding Disorders Awareness Month\, and in recognition of Von Willebrand Disease (VWD) Awareness Week (March 1–7)\, we are pleased to host the virtual educational session “Discover a New Investigational Approach to VWD Treatment” featuring Star Therapeutics. \nStar Therapeutics is currently investigating VGA039\, a potential once-monthly subcutaneous prophylactic treatment for VWD. \nIf you or someone in your family has any type of VWD or you are curious about new therapies in the bleeding disorders community\, we invite you to join us for this informative and engaging session. Dr. Laura Guido\, Head of Medical Affairs at Star Therapeutics\, will discuss: \n\nHow VGA039 works\nThe clinical development pathway for this investigational therapy\nEarly clinical trial results\nInformation about the VIVID Clinical Trials\, including how to explore eligibility and participation\n\n\nFeatured Speaker\nLaura Guido\, PharmD\, MBA\, BCPSExecutive Director\, Medical Affairs\, Star Therapeutics \nDr. Guido is a clinical pharmacist who leads Medical Affairs for VGA039 at Star Therapeutics. Prior to joining Star\, she supported clinical development for hemophilia A gene therapy trials at BioMarin and spent several years working in anticoagulation at Boehringer Ingelheim. Before transitioning to industry\, Dr. Guido practiced as a clinical pharmacist.
URL:https://vahemophilia.org/event-program/virtual-education-session-discover-a-new-investigational-approach-to-vwd-treatment/
LOCATION:Zoom
END:VEVENT
END:VCALENDAR